Green Cross Holdings Corporation (005250.KS)
KRW 12720.0
(0.32%)
KRW 12720.0
(0.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3737.7 Billion KRW | 4.05% |
| 2022 | 3592.06 Billion KRW | 2.72% |
| 2021 | 3496.83 Billion KRW | 7.89% |
| 2020 | 3241.2 Billion KRW | 16.85% |
| 2019 | 2773.86 Billion KRW | 5.53% |
| 2018 | 2628.59 Billion KRW | 2.65% |
| 2017 | 2560.69 Billion KRW | 13.85% |
| 2016 | 2249.27 Billion KRW | 9.26% |
| 2015 | 2058.66 Billion KRW | 14.95% |
| 2014 | 1790.87 Billion KRW | 10.27% |
| 2013 | 1624.12 Billion KRW | 12.29% |
| 2012 | 1446.33 Billion KRW | -68.58% |
| 2011 | 4603.21 Billion KRW | 11.96% |
| 2010 | 4111.33 Billion KRW | 22.88% |
| 2009 | 3345.83 Billion KRW | 20.2% |
| 2008 | 2783.54 Billion KRW | 14.47% |
| 2007 | 2431.62 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3781.72 Billion KRW | 1.2% |
| 2024 Q1 | 3736.86 Billion KRW | -0.02% |
| 2023 Q2 | 3625.73 Billion KRW | 1.2% |
| 2023 FY | 3737.7 Billion KRW | 4.05% |
| 2023 Q3 | 3731.08 Billion KRW | 2.91% |
| 2023 Q4 | 3737.7 Billion KRW | 0.18% |
| 2023 Q1 | 3582.77 Billion KRW | -0.26% |
| 2022 Q4 | 3592.06 Billion KRW | -1.71% |
| 2022 Q2 | 3534.26 Billion KRW | 0.84% |
| 2022 FY | 3592.06 Billion KRW | 2.72% |
| 2022 Q1 | 3504.67 Billion KRW | 0.22% |
| 2022 Q3 | 3654.52 Billion KRW | 3.4% |
| 2021 Q3 | 3328.27 Billion KRW | 0.32% |
| 2021 Q2 | 3317.77 Billion KRW | -0.17% |
| 2021 Q4 | 3496.83 Billion KRW | 5.06% |
| 2021 FY | 3496.83 Billion KRW | 7.89% |
| 2021 Q1 | 3323.42 Billion KRW | 2.54% |
| 2020 FY | 3241.2 Billion KRW | 16.85% |
| 2020 Q4 | 3241.2 Billion KRW | -0.46% |
| 2020 Q2 | 3184.31 Billion KRW | 14.41% |
| 2020 Q1 | 2783.28 Billion KRW | 0.34% |
| 2020 Q3 | 3256.29 Billion KRW | 2.26% |
| 2019 Q4 | 2773.86 Billion KRW | 1.5% |
| 2019 FY | 2773.86 Billion KRW | 5.53% |
| 2019 Q1 | 2602.89 Billion KRW | -0.98% |
| 2019 Q2 | 2656.43 Billion KRW | 2.06% |
| 2019 Q3 | 2732.81 Billion KRW | 2.88% |
| 2018 Q2 | 2617.89 Billion KRW | 1.35% |
| 2018 Q1 | 2583.14 Billion KRW | 0.88% |
| 2018 FY | 2628.59 Billion KRW | 2.65% |
| 2018 Q4 | 2628.59 Billion KRW | -1.02% |
| 2018 Q3 | 2655.72 Billion KRW | 1.44% |
| 2017 Q4 | 2560.69 Billion KRW | 2.89% |
| 2017 Q2 | 2412.34 Billion KRW | 7.76% |
| 2017 Q1 | 2238.69 Billion KRW | -0.47% |
| 2017 FY | 2560.69 Billion KRW | 13.85% |
| 2017 Q3 | 2488.68 Billion KRW | 3.16% |
| 2016 Q4 | 2249.27 Billion KRW | -0.16% |
| 2016 Q3 | 2252.95 Billion KRW | 1.05% |
| 2016 Q2 | 2229.51 Billion KRW | 6.54% |
| 2016 Q1 | 2092.66 Billion KRW | 1.65% |
| 2016 FY | 2249.27 Billion KRW | 9.26% |
| 2015 FY | 2058.66 Billion KRW | 14.95% |
| 2015 Q1 | 1844.34 Billion KRW | 2.99% |
| 2015 Q2 | 1977.49 Billion KRW | 7.22% |
| 2015 Q3 | 1978.02 Billion KRW | 0.03% |
| 2015 Q4 | 2058.66 Billion KRW | 4.08% |
| 2014 Q4 | 1790.87 Billion KRW | 1.32% |
| 2014 Q3 | 1767.54 Billion KRW | 1.46% |
| 2014 Q2 | 1742.16 Billion KRW | 3.76% |
| 2014 Q1 | 1678.99 Billion KRW | 3.38% |
| 2014 FY | 1790.87 Billion KRW | 10.27% |
| 2013 FY | 1624.12 Billion KRW | 12.29% |
| 2013 Q1 | 1451.76 Billion KRW | 0.38% |
| 2013 Q2 | 1585.11 Billion KRW | 9.19% |
| 2013 Q3 | 1623.68 Billion KRW | 2.43% |
| 2013 Q4 | 1624.12 Billion KRW | 0.03% |
| 2012 FY | 1446.33 Billion KRW | -68.58% |
| 2012 Q3 | 1474.99 Billion KRW | 5.49% |
| 2012 Q4 | 1446.33 Billion KRW | -1.94% |
| 2012 Q1 | 1365.13 Billion KRW | -70.34% |
| 2012 Q2 | 1398.21 Billion KRW | 2.42% |
| 2011 FY | 4603.21 Billion KRW | 11.96% |
| 2011 Q4 | 4603.21 Billion KRW | 1.71% |
| 2011 Q3 | 4525.97 Billion KRW | 3.55% |
| 2011 Q2 | 4370.95 Billion KRW | 3.36% |
| 2011 Q1 | 4228.74 Billion KRW | 0.0% |
| 2010 Q3 | 845.9 Billion KRW | 38.4% |
| 2010 FY | 4111.33 Billion KRW | 22.88% |
| 2010 Q1 | 556.49 Billion KRW | 0.0% |
| 2010 Q2 | 611.18 Billion KRW | 9.83% |
| 2009 FY | 3345.83 Billion KRW | 20.2% |
| 2009 Q3 | 485.52 Billion KRW | 6.97% |
| 2009 Q2 | 453.9 Billion KRW | 10.65% |
| 2009 Q1 | 410.2 Billion KRW | 0.0% |
| 2008 Q2 | 403.99 Billion KRW | 3.38% |
| 2008 Q3 | 384.72 Billion KRW | -4.77% |
| 2008 FY | 2783.54 Billion KRW | 14.47% |
| 2008 Q1 | 390.79 Billion KRW | 0.0% |
| 2007 FY | 2431.62 Billion KRW | 0.0% |
| 2007 Q1 | 382.91 Billion KRW | 0.0% |
| 2007 Q2 | 407.6 Billion KRW | 6.45% |
| 2007 Q3 | 416.48 Billion KRW | 2.18% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ORIENT BIO Inc. | 96.98 Billion KRW | -3753.792% |
| Green Cross Holdings Corporation | 2643.31 Billion KRW | -41.402% |
| Pharmicell Co., Ltd. | 99.19 Billion KRW | -3668.181% |
| Green Cross Corporation | 2643.31 Billion KRW | -41.402% |
| GeneOne Life Science, Inc. | 151 Billion KRW | -2375.177% |
| Celltrion, Inc. | 19917.53 Billion KRW | 81.234% |
| Samsung Biologics Co.,Ltd. | 16046.19 Billion KRW | 76.707% |
| SK bioscience Co.,Ltd. | 1852.43 Billion KRW | -101.772% |
| SK Biopharmaceuticals Co., Ltd. | 723.17 Billion KRW | -416.85% |
| Prestige BioPharma Limited | 711.72 Billion KRW | -425.165% |